Display options
Share it on

Genome Med. 2009 Mar 25;1(3):33. doi: 10.1186/gm33.

Chipping away at the common epilepsies with complex genetics: the 15q13.3 microdeletion shows the way.

Genome medicine

John C Mulley, Leanne M Dibbens

Affiliations

  1. Epilepsy Research Program, Genetics and Molecular Pathology, SA Pathology at the Women's and Children's Hospital, 72 King William Road, North Adelaide, SA 5006, Australia.

PMID: 19341504 PMCID: PMC2664944 DOI: 10.1186/gm33

Abstract

The idiopathic epilepsies are genetically heterogeneous with more than 50 clinical classifications. They are characterized by episodic seizures arising from erratic neuronal discharge in susceptible individuals. The most common predisposing genetic cause is the recently discovered chromosome 15q13.3 microdeletion. Other disorders previously attributed to the same lesion include autism, intellectual disability and schizophrenia. This phenotypic spectrum is most easily imagined as a contiguous gene syndrome with idiopathic generalized epilepsy as the most common clinical manifestation. Expressivity of the microdeletion in carriers is too variable for antenatal prediction of phenotype to be possible; however, when it is detected in living affected cases, it can be taken as the major predisposing cause for the observed phenotype. The discovery of this small 15q13.3 lesion barely scratches the surface that conceals what we ultimately need to know about the molecular genetic mechanisms behind the common epilepsies with complex genetics, but it provides valuable insight into how to proceed toward that goal.

References

  1. Nature. 2008 Sep 11;455(7210):237-41 - PubMed
  2. Epilepsia. 2001 Apr;42(4):464-75 - PubMed
  3. Hum Mol Genet. 1997 Aug;6(8):1329-34 - PubMed
  4. J Med Genet. 2009 Apr;46(4):242-8 - PubMed
  5. Nat Genet. 1995 May;10(1):4-6 - PubMed
  6. Neurology. 2009 Feb 10;72(6):558-65 - PubMed
  7. Am J Hum Genet. 2003 Apr;72(4):785-803 - PubMed
  8. Lancet Neurol. 2007 Nov;6(11):970-80 - PubMed
  9. J Neurosci. 1997 Dec 1;17(23):9165-71 - PubMed
  10. Science. 2007 Apr 20;316(5823):445-9 - PubMed
  11. Nat Genet. 2009 Feb;41(2):160-2 - PubMed
  12. Genes Brain Behav. 2006 Aug;5(6):433-40 - PubMed
  13. Nat Genet. 1998 Jan;18(1):53-5 - PubMed
  14. Hum Mutat. 2009 Feb;30(2):135-44 - PubMed
  15. Epilepsy Res. 2002 Apr;49(2):157-72 - PubMed
  16. Nat Genet. 1995 Oct;11(2):201-3 - PubMed
  17. Science. 2008 Apr 25;320(5875):539-43 - PubMed
  18. Neurobiol Dis. 2008 Dec;32(3):349-54 - PubMed
  19. Trends Genet. 1998 Oct;14(10):417-22 - PubMed
  20. Nat Genet. 2008 Mar;40(3):322-8 - PubMed
  21. Brain Dev. 2009 May;31(5):394-400 - PubMed
  22. Hum Mol Genet. 2005 Oct 15;14 Spec No. 2:R243-9 - PubMed
  23. Science. 1998 Jan 16;279(5349):403-6 - PubMed
  24. Am J Hum Genet. 2007 Apr;80(4):727-39 - PubMed
  25. Nat Genet. 1998 Aug;19(4):366-70 - PubMed
  26. Genes Brain Behav. 2007 Oct;6(7):593-7 - PubMed
  27. Neurotherapeutics. 2007 Apr;4(2):295-304 - PubMed
  28. Nature. 2008 Sep 11;455(7210):232-6 - PubMed
  29. Epilepsia. 2004 Nov;45(11):1429-42 - PubMed
  30. J Biol Chem. 2008 May 2;283(18):11897-904 - PubMed
  31. Nat Genet. 1998 Jan;18(1):25-9 - PubMed
  32. Neurosci Lett. 2009 Apr 10;453(3):162-5 - PubMed

Publication Types